12 research outputs found
Surgical safety checklist: An integrative review of the benefits and importance / Lista de verificação de segurança cirúrgica: Uma revisão integrativa sobre benefícios e sua importância
Objetivo: Analisar, com base na literatura, os benefícios da implantação da lista de verificação de segurança cirúrgica. Método: revisão integrativa norteada pela questão: “Quais os benefícios da utilização da lista de verificação de segurança cirúrgica segura para a melhoria na qualidade em serviços de saúde?”. O levantamento dos artigos foi realizado em base de dados Medline via Pub Med, Lilacs, Bdenf via Biblioteca Virtual em Saúde, publicados no período de 2010 a 2014. Resultados: Mediante os achados emergiram o agrupamento por similaridade de resultados “benefícios da utilização da lista de verificação de segurança cirúrgica” e “importância da lista de verificação de segurança cirúrgica na redução da morbidade iatrogênica causando desfechos indesejáveis”. Conclusão: A análise permitiu evidenciar que a implementação da lista de verificação da cirurgia segura está associada a melhores resultados e estabelece processos seguros na assistência cirúrgica. Descritores: Lista de checagem, Segurança do paciente, Salas cirúrgicas
The Indiscriminate use of Ritalin by Universities in the Health Area at the University of Gurupi – UNIRG
MPH methylphenidate, popularly known as Ritalin, was synthesized in 1954 in Switzerland and marketed in Brazil in 1998, belonging to the class of amphetamines. It acts in the CNS crossing the blood-brain barrier very easily. Used for cognitive improvement by college students. Its excessive consumption leads to dependence and possible side effects. The objective of this study was to analyze 91 university students who answered questionnaires on the theme. The collected data analyzed the incidence of Ritalin use among health academics at the University of Gurupi-UNIRG. After conducting the surveys, it was intended to understand the real reason that leads the student to the indiscriminate use of the drug and its possible consequences, to subsequently conduct guidance regarding the use without a prescription for academic purposes
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3) : analysis of individual data from 258 cancer registries in 61 countries
Background Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed
data for children (aged 0–14 years) and adults (aged 15–99 years) diagnosed with a haematological malignancy
during 2000–14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and
morphology, in young patients (aged 0–24 years).
Methods We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3
that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0–14 years),
adolescents (15–19 years), and young adults (20–24 years). We categorised leukaemia subtypes according to the
International Classification of Childhood Cancer (ICCC-3), updated with International Classification of Diseases
for Oncology, third edition (ICD-O-3) codes. We estimated 5-year net survival by age and morphology, with 95% CIs,
using the non-parametric Pohar-Perme estimator. To control for background mortality, we used life tables by
country or region, single year of age, single calendar year and sex, and, where possible, by race or ethnicity. All-age
survival estimates were standardised to the marginal distribution of young people with leukaemia included in the
analysis.
Findings 164563 young people were included in this analysis: 121328 (73·7%) children, 22963 (14·0%) adolescents, and
20272 (12·3%) young adults. In 2010–14, the most common subtypes were lymphoid leukaemia (28205 [68·2%] patients)
and acute myeloid leukaemia (7863 [19·0%] patients). Age-standardised 5-year net survival in children, adolescents, and
young adults for all leukaemias combined during 2010–14 varied widely, ranging from 46% in Mexico to more than
85% in Canada, Cyprus, Belgium, Denmark, Finland, and Australia. Individuals with lymphoid leukaemia had better
age-standardised survival (from 43% in Ecuador to ≥80% in parts of Europe, North America, Oceania, and Asia) than
those with acute myeloid leukaemia (from 32% in Peru to ≥70% in most high-income countries in Europe,
North America, and Oceania). Throughout 2000–14, survival from all leukaemias combined remained consistently
higher for children than adolescents and young adults, and minimal improvement was seen for adolescents and young
adults in most countries.
Interpretation This study offers the first worldwide picture of population-based survival from leukaemia in children,
adolescents, and young adults. Adolescents and young adults diagnosed with leukaemia continue to have lower
survival than children. Trends in survival from leukaemia for adolescents and young adults are important indicators
of the quality of cancer management in this age group.peer-reviewe
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)
Background:
Survival is a key metric of the effectiveness of a health system in managing cancer. We set out to provide a comprehensive examination of worldwide variation and trends in survival from brain tumors in adults, by histology.
Methods:
We analyzed individual data for adults (15–99 years) diagnosed with a brain tumor (ICD-O-3 topography code C71) during 2000–2014, regardless of tumor behavior. Data underwent a 3-phase quality control as part of CONCORD-3. We estimated net survival for 11 histology groups, using the unbiased nonparametric Pohar Perme estimator.
Results:
The study included 556,237 adults. In 2010–2014, the global range in age-standardized 5-year net survival for the most common sub-types was broad: in the range 20%–38% for diffuse and anaplastic astrocytoma, from 4% to 17% for glioblastoma, and between 32% and 69% for oligodendroglioma. For patients with glioblastoma, the largest gains in survival occurred between 2000–2004 and 2005–2009. These improvements were more noticeable among adults diagnosed aged 40–70 years than among younger adults.
Conclusions:
To the best of our knowledge, this study provides the largest account to date of global trends in population-based survival for brain tumors by histology in adults. We have highlighted remarkable gains in 5-year survival from glioblastoma since 2005, providing large-scale empirical evidence on the uptake of chemoradiation at population level. Worldwide, survival improvements have been extensive, but some countries still lag behind. Our findings may help clinicians involved in national and international tumor pathway boards to promote initiatives aimed at more extensive implementation of clinical guidelines
Surgical safety checklist: An integrative review of the benefits and importance / Lista de verificação de segurança cirúrgica: Uma revisão integrativa sobre benefícios e sua importância
Objetivo: Analisar, com base na literatura, os benefícios da implantação da lista de verificação de segurança cirúrgica. Método: revisão integrativa norteada pela questão: “Quais os benefícios da utilização da lista de verificação de segurança cirúrgica segura para a melhoria na qualidade em serviços de saúde?”. O levantamento dos artigos foi realizado em base de dados Medline via Pub Med, Lilacs, Bdenf via Biblioteca Virtual em Saúde, publicados no período de 2010 a 2014. Resultados: Mediante os achados emergiram o agrupamento por similaridade de resultados “benefícios da utilização da lista de verificação de segurança cirúrgica” e “importância da lista de verificação de segurança cirúrgica na redução da morbidade iatrogênica causando desfechos indesejáveis”. Conclusão: A análise permitiu evidenciar que a implementação da lista de verificação da cirurgia segura está associada a melhores resultados e estabelece processos seguros na assistência cirúrgica. Descritores: Lista de checagem, Segurança do paciente, Salas cirúrgicas
Surgical safety checklist: An integrative review of the benefits and importance
Objective: To analyze, based on the literature, the benefits of implementing surgical safety checklist.
Method: Integrative review guided by the question: “What are the benefits of using safe surgical safety
checklist to improve the quality of health services?”. The survey of the articles was conducted in Medline via
Pub Med, Lilacs, BDEnf via Virtual Health Library, published from 2010 to 2014. Results: Through the findings
emerged grouping by similarity of results “benefits of using the list surgical safety check” and “importance
of surgical safety checklist in reducing iatrogenic morbidity causing undesirable outcomes”. Conclusion: The
analysis has highlighted that the implementation of the safe surgery checklist is associated with better outcomes
and establishes safe procedures in surgical care.Objetivo: Analisar, com base na literatura, os benefícios da implantação da lista de verificação de segurança cirúrgica. Método: revisão integrativa norteada pela questão: “Quais os benefícios da utilização da lista de verificação de segurança cirúrgica segura para a melhoria na qualidade em serviços de saúde?”. O levantamento dos artigos foi realizado em base de dados Medline via Pub Med, Lilacs, Bdenf via Biblioteca Virtual em Saúde, publicados no período de 2010 a 2014. Resultados: Mediante os achados emergiram o agrupamento por similaridade de resultados “benefícios da utilização da lista de verificação de segurança cirúrgica” e “importância da lista de verificação de segurança cirúrgica na redução da morbidade iatrogênica causando desfechos indesejáveis”. Conclusão: A análise permitiu evidenciar que a implementação da lista de verificação da cirurgia segura está associada a melhores resultados e estabelece processos seguros na assistência cirúrgica.Objetivo: Analizar, con base en la literatura, los beneficios de implementar
lista de seguridad quirúrgica. Método: Revisión integradora guiado por la
pregunta: “Cuáles son los beneficios de usar seguro lista de verificación de
seguridad quirúrgica para mejorar la calidad de los servicios de salud”. La
encuesta de los artículos se realizó en la base de datos Medline vía PubMed,
Lilacs, BDEnf través de la Biblioteca Virtual en Salud, publicada entre 2010
y 2014. Resultados: A través de los hallazgos emergieron agrupación por
similitud de resultados “beneficios del uso de la lista verificación quirúrgica de
seguridad” y “importancia de la lista de verificación de seguridad quirúrgica
para reducir la morbilidad iatrogénica provocando resultados indeseables.”
Conclusión: El análisis ha puesto de manifiesto que la aplicación de la lista
de verificación quirúrgica segura se asocia con mejores resultados y establece
los procedimientos de seguridad en la atención quirúrgica. Palabras clave:
lista de comprobación; la seguridad del paciente; Centro quirúrgico
Resumos concluídos - Saúde Coletiva
Resumos concluídos - Saúde Coletiv
Resumos concluídos - Saúde Coletiva
Resumos concluídos - Saúde Coletiv
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries
Background:
Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0–14 years) and adults (aged 15–99 years) diagnosed with a haematological malignancy during 2000–14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0–24 years).
Methods:
We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0–14 years), adolescents (15–19 years), and young adults (20–24 years). We categorised leukaemia subtypes according to the International Classification of Childhood Cancer (ICCC-3), updated with International Classification of Diseases for Oncology, third edition (ICD-O-3) codes. We estimated 5-year net survival by age and morphology, with 95% CIs, using the non-parametric Pohar-Perme estimator. To control for background mortality, we used life tables by country or region, single year of age, single calendar year and sex, and, where possible, by race or ethnicity. All-age survival estimates were standardised to the marginal distribution of young people with leukaemia included in the analysis.
Findings:
164 563 young people were included in this analysis: 121 328 (73·7%) children, 22 963 (14·0%) adolescents, and 20 272 (12·3%) young adults. In 2010–14, the most common subtypes were lymphoid leukaemia (28 205 [68·2%] patients) and acute myeloid leukaemia (7863 [19·0%] patients). Age-standardised 5-year net survival in children, adolescents, and young adults for all leukaemias combined during 2010–14 varied widely, ranging from 46% in Mexico to more than 85% in Canada, Cyprus, Belgium, Denmark, Finland, and Australia. Individuals with lymphoid leukaemia had better age-standardised survival (from 43% in Ecuador to ≥80% in parts of Europe, North America, Oceania, and Asia) than those with acute myeloid leukaemia (from 32% in Peru to ≥70% in most high-income countries in Europe, North America, and Oceania). Throughout 2000–14, survival from all leukaemias combined remained consistently higher for children than adolescents and young adults, and minimal improvement was seen for adolescents and young adults in most countries.
Interpretation:
This study offers the first worldwide picture of population-based survival from leukaemia in children, adolescents, and young adults. Adolescents and young adults diagnosed with leukaemia continue to have lower survival than children. Trends in survival from leukaemia for adolescents and young adults are important indicators of the quality of cancer management in this age group